{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:23:45Z","timestamp":1774610625774,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00520-017-3628-5","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T01:53:12Z","timestamp":1487123592000},"page":"2221-2227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Skeletal muscle loss and prognosis of breast cancer patients"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2807-9609","authenticated-orcid":false,"given":"Yoshiko","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tateaki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gakuji","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Aruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"3628_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"3628_CR2","first-page":"888","volume-title":"Oxford textbook of palliative medicine","author":"H Geoffery","year":"2011","unstructured":"Geoffery H, Nathan IC, Nicholas AC, Marie F, Stein K, Russell KP (2011) Weight loss in palliative medicine. In: Oxford textbook of palliative medicine, 4th edn. Oxford University Press Inc., New York, pp 888\u2013907","edition":"4th"},{"key":"3628_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0899-9007(96)80061-X","volume":"12","author":"A Laviano","year":"1996","unstructured":"Laviano A, Meguid MM (1996) Nutritional issues in cancer management. Nutrition 12:358\u2013371","journal-title":"Nutrition"},{"key":"3628_CR4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539\u20131547","journal-title":"J Clin Oncol"},{"key":"3628_CR5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","volume":"89","author":"MJ Tisdale","year":"1997","unstructured":"Tisdale MJ (1997) Biology of cachexia. J Natl Cancer Inst 89:1763\u20131773","journal-title":"J Natl Cancer Inst"},{"key":"3628_CR6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629\u2013635","journal-title":"Lancet Oncol"},{"key":"3628_CR7","doi-asserted-by":"crossref","first-page":"e0140403","DOI":"10.1371\/journal.pone.0140403","volume":"10","author":"S Aust","year":"2015","unstructured":"Aust S, Knogler T, Pils D, Obermayr E, Reinthaller A, Zahn L, Radlgruber I, Mayerhoefer ME, Grimm C, Polterauer S (2015) Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer. PLoS One 10:e0140403","journal-title":"PLoS One"},{"key":"3628_CR8","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","volume":"18","author":"MS Sabel","year":"2011","unstructured":"Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S (2011) Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 18:3579\u20133585","journal-title":"Ann Surg Oncol"},{"key":"3628_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","volume":"63","author":"N Fujiwara","year":"2015","unstructured":"Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami T et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131\u2013140","journal-title":"J Hepatol"},{"key":"3628_CR10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11764-012-0234-x","volume":"6","author":"A Villasenor","year":"2012","unstructured":"Villasenor A, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A, Neuhouser ML (2012) Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL study. J Cancer Surviv 6:398\u2013406","journal-title":"J Cancer Surviv"},{"key":"3628_CR11","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920\u20132926","journal-title":"Clin Cancer Res"},{"key":"3628_CR12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3945\/ajcn.113.060228","volume":"98","author":"CM Prado","year":"2013","unstructured":"Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, Baracos VE (2013) Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutrition 98:1012\u20131019","journal-title":"Am J Clin Nutrition"},{"key":"3628_CR13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"3628_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","volume":"85","author":"N Mitsiopoulos","year":"1998","unstructured":"Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R (1998) Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (Bethesda, Md: 1985) 85:115\u2013122","journal-title":"J Appl Physiol (Bethesda, Md: 1985)"},{"key":"3628_CR15","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (Bethesda, Md: 1985) 97:2333\u20132338","journal-title":"J Appl Physiol (Bethesda, Md: 1985)"},{"key":"3628_CR16","first-page":"3","volume":"3","author":"N Esfandiari","year":"2014","unstructured":"Esfandiari N, Ghosh S, Prado CMM, Martin L, Mazurek V, Baracos VE (2014) Age, obesity, sarcopenia, and proximity to death explain reduced mean muscle attenuation in patients with advanced cancer. J Frailty Aging 3:3\u20138","journal-title":"J Frailty Aging"},{"key":"3628_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","volume":"89","author":"BH Goodpaster","year":"2000","unstructured":"Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (Bethesda, Md: 1985) 89:104\u2013110","journal-title":"J Appl Physiol (Bethesda, Md: 1985)"},{"key":"3628_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1748-1716.1993.tb09573.x","volume":"148","author":"HE Berg","year":"1993","unstructured":"Berg HE, Tedner B, Tesch PA (1993) Changes in lower limb muscle cross-sectional area and tissue fluid volume after transition from standing to supine. Acta Physiol Scand 148:379\u2013385","journal-title":"Acta Physiol Scand"},{"key":"3628_CR19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","volume":"89","author":"JR Lieffers","year":"2009","unstructured":"Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CM, Baracos VE (2009) A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutrition 89:1173\u20131179","journal-title":"Am J Clin Nutrition"},{"key":"3628_CR20","doi-asserted-by":"crossref","unstructured":"van Dijk DP, Bakens MJ, Coolsen MM, Rensen SS, van Dam RM, Bours MJ, Weijenberg MP, Dejong CH, Olde Damink SW (2016) Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer. J Cachexia Sarcopenia Muscle","DOI":"10.1002\/jcsm.12155"},{"key":"3628_CR21","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00520-016-3287-y","volume":"24","author":"D Srdic","year":"2016","unstructured":"Srdic D, Plestina S, Sverko-Peternac A, Nikolac N, Simundic AM, Samarzija M (2016) Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value. Suppor Care Cancer 24:4495\u20134502","journal-title":"Suppor Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3628-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T14:00:23Z","timestamp":1568815223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3628"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3628-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]}}}